OMedLive CME Courses

OMedLive CME Courses

Format: Online Streaming Video
Price: Free
Release Date: 9/29/2017
Expiration Date: 9/29/2018
Summary:

This activity is intended for pediatric oncology nurses, pediatric nurses, oncology nurses, nurse practitioners, nurse managers, infusion nurses, research nurses, physician assistants, and other health care providers who care for or have an interest in pediatric patients with high-risk neuroblastoma

Format: Interactive Online
Price: Free
Expiration Date: 6/14/18
Summary:

Speakers:

Matthew H. Kulke, MD, MMSc, Associate Professor of Medicine, Director of the Neuroendocrine and Carcinoid Tumor Program at Dana-Farber Cancer Institute and a professor of medicine at Harvard Medical School

David C. Metz, MBBCh, is Professor of Medicine at the Perelman School of Medicine (University of Pennsylvania)

Topic and Learning Objectives

  • To incorporate evidence-based practices into the management of carcinoid syndrome
  • Review the efficacy and safety of treatment programs for carcinoid syndrome
  • To summarize the causes of carcinoid syndrome
  • Review the differential diagnosis and appropriate workup for the presenting symptoms

This activity is intended for US-based medical oncologists, endocrinologists and gastroenterologists, as well as oncology physician assistants, nurse practitioners, and nurses involved in the diagnosis and management of carcinoid tumors and carcinoid syndrome. Considering the symptoms and potential complications involved in carcinoid syndrome, clinicians in cardiology, dermatology, pulmonary medicine, surgery, radiology (including interventional, diagnostic, and nuclear medicine), internal medicine and primary care may also benefit from education.

Format: Online Streaming Video
Price: Free
Release Date: September 13, 2017
Expiration Date: March 13th, 2018
Summary:

TOPICS OF INTEREST:

  • Disease- and patient-factors influencing treatment choices at relapse
  • Mechanisms of drug resistance and clonal heterogeneity
  • Emerging agents: Immunodulatory derivatives, novel pathway targets, second-generation proteasome inhibitors, and monoclonal antibodies
  • Drawing on clinical trials of emerging therapies to benefit patients



Format: Online Streaming Video
Price: Free
Release Date: 8/24/2017
Expiration Date: 2/24/2018
Summary:

This activity is intended for medical and radiation oncologists, head and neck surgeons, otolaryngologists, ear, nose and throat (ENT) specialists, and other health care professionals (primary care providers, physicians–in–training, oncology nurses, nurse practitioners, pharmacists, physician assistants, etc.) involved and/or interested in the therapeutic management of patients with head and neck cancer

Format: Interactive Online
Price: Free
Expiration Date: 12/28/17
Summary:

Speaker

Richard S. Finn, MD, is an assistant professor of medicine in the Department of Medicine, Division of Hematology/ Oncology, at the Geffen School of Medicine at the University of California, Los Angeles (UCLA).

Topic and Learning Objectives:

  • Review advances and challenges of treating HR+, HER2- advanced and metastatic breast cancer
  • Evaluate efficacy and safety data of CDK4/6 inhibitors for HR+, HER2- advanced and metastatic breast cancer
  • Discuss effective strategies to manage CDK4/6 inhibitor treatment-related side effects
Format: Online Streaming Video
Price: Free
Release Date: August 11, 2017
Expiration Date: February 11, 2018
Summary:

  

TOPICS OF INTEREST:

  • Clinical data on emerging new agents
  • Immunotherapy and chemotherapy selection
  • Multimodal therapies
  • Clinical trials for bladder cancer



Share This